Stéphane Nancey
7PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 28, 2025
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.Marie André, Julien Kirchgesner, David Laharie
|Jul 12, 2025
Advances in Understanding Intestinal Homeostasis: Lessons from Inflammatory Bowel Disease and Monogenic Intestinal Disorder Pathogenesis.Céline Petit, Aurore Rozières, Gilles Boschetti
|Aug 09, 2024
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.Bénédicte Caron, Philippe Seksik, Anthony Buisson
|May 11, 2024
Prevalence of the Oral Corticosteroid Exposure and Excessive Use in Patients with Inflammatory Bowel Disease: Data from Four French Referral Centers of the International DICE Study.Stéphane Nancey, Xavier Hébuterne, Cyrielle Gilletta
|Apr 14, 2024
Impaired reprogramming of the autophagy flux in maturing dendritic cells from crohn disease patients with core autophagy gene-related polymorphisms.Gaëlle Quiniou, Leslie Andromaque, Rémi Duclaux-Loras
|May 27, 2023
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.Xavier Roblin, Gérard Duru, Konstantinos Papamichael
Pageof 2
